IN BRIEF: ReNeuron promotes Financial Controller Hawkins to CFO
AJ Bell Youinvest is an easy to use, award-winning platform Open an account
We’ve accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Writer, Alliance News
Wednesday, September 14, 2022 – 13:19
But if you need to speak to us, take a look at how to get in touch.
ReNeuron Group PLC – Bridgend, Wales-based stem cell and exosomes technology company – Promotes Financial Controller John Hawkins to chief financial officer with immediate effect. Hawkins joined the company in 2014 as financial controller and was also named as the company secretary last year. Says Hawkins is an experienced finance professional with a breadth of experience gained within ‘a variety of businesses, from large PLCs to family-owned SMEs’.
ReNeuron also names Simon Dew as chief business officer, who currently is a senior healthcare executive with extensive experience in Business Development and Corporate Strategy. Most recently, he worked at biotechnology company Evox Therapeutics Ltd, where he was responsible for leading two transformational partnership deals with global pharmaceutical companies.
Chief Executive Officer Catherine Isted says: ‘[Hawkins] has been a key part of the team redefining the operational and strategic focus of the group and his extensive knowledge of the business and tireless work ethic have been invaluable especially in this period of transition. The appointment of Simon Dew as CBO will be a key role in the new ReNeuron executive team to maximise the opportunity we see ahead of us in the field and to accelerate our partnership opportunities.’
Current stock price: 26.32 pence, down 2.5%
12-month change: down 74%
Copyright 2022 Alliance News Limited. All Rights Reserved.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don’t offer advice, so it’s important you understand the risks, if you’re unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.
Follow us: AJ Bell Youinvest
About AJ Bell Youinvest Security centre Part of AJ Bell Authorised and regulated by the Financial Conduct Authority.
AJ Bell Youinvest registered office: AJ Bell Youinvest, 4 Exchange Quay, Salford Quays, Manchester, M5 3EE.